Literature DB >> 19959252

An investigation on electronic nose diagnosis of lung cancer.

Arnaldo D'Amico1, Giorgio Pennazza, Marco Santonico, Eugenio Martinelli, Claudio Roscioni, Giovanni Galluccio, Roberto Paolesse, Corrado Di Natale.   

Abstract

The use of gas sensor arrays as medical diagnosis instruments has been proposed several years ago. Since then, the idea has been proven for a limited number of diseases. The case of lung cancer is particularly interesting because it is supported by studies that have shown the correlation between the composition of breath and the disease. However, it is known that many other diseases can alter the breath composition, so for lung cancer diagnosis it is necessary not only to detect generic alterations but those specifically consequent to cancer. In this paper an experiment, performed in the bronchoscopy unit of a large hospital, aimed at discriminating between lung cancer, diverse lung diseases and reference controls is illustrated. Results show not only a satisfactory identification rate of lung cancer subjects but also a non-negligible sensitivity to breath modification induced by other affections. Furthermore, the effects of some compounds frequently found in the breath of lung cancer subjects have also been studied. Results indicate that breath samples of control individuals drift towards the lung cancer group when added with either single or mixtures of these alleged cancer-related compounds. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959252     DOI: 10.1016/j.lungcan.2009.11.003

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  49 in total

Review 1.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

Review 2.  Electronic Nose Technology in Respiratory Diseases.

Authors:  Silvano Dragonieri; Giorgio Pennazza; Pierluigi Carratu; Onofrio Resta
Journal:  Lung       Date:  2017-02-25       Impact factor: 2.584

3.  Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.

Authors:  Laszlo Kunos; Andras Bikov; Zsofia Lazar; Beata Zita Korosi; Palma Benedek; Gyorgy Losonczy; Ildiko Horvath
Journal:  Sleep Breath       Date:  2014-05-20       Impact factor: 2.816

4.  Biomimetic Cross-Reactive Sensor Arrays: Prospects in Biodiagnostics.

Authors:  J E Fitzgerald; H Fenniri
Journal:  RSC Adv       Date:  2016-08-17       Impact factor: 3.361

5.  A Novel Framework with High Diagnostic Sensitivity for Lung Cancer Detection by Electronic Nose.

Authors:  Binchun Lu; Lidan Fu; Bo Nie; Zhiyun Peng; Hongying Liu
Journal:  Sensors (Basel)       Date:  2019-12-03       Impact factor: 3.576

6.  Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples.

Authors:  Nicola M Zetola; Chawangwa Modongo; Ogopotse Matsiri; Tsaone Tamuhla; Bontle Mbongwe; Keikantse Matlhagela; Enoch Sepako; Alexandro Catini; Giorgio Sirugo; Eugenio Martinelli; Roberto Paolesse; Corrado Di Natale
Journal:  J Infect       Date:  2016-12-22       Impact factor: 6.072

7.  Bronchoscopically obtained volatile biomarkers in lung cancer.

Authors:  Kaid Darwiche; Joerg Ingo Baumbach; Urte Sommerwerck; Helmut Teschler; Lutz Freitag
Journal:  Lung       Date:  2011-10-04       Impact factor: 2.584

Review 8.  Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

Authors:  Brielle A Parris; Hannah E O'Farrell; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 9.  Personalised medicine and asthma diagnostics/management.

Authors:  Samuel J Wadsworth; Andrew J Sandford
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 10.  Exhaled breath analysis for lung cancer.

Authors:  Annette G Dent; Tom G Sutedja; Paul V Zimmerman
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.